COT-13 Current situation and problems of cancer genomic profiling test in Kyoto University Hospital

Objective: Kyoto University Hospital has introduced the cancer genomic profiling tests, Oncoprime in 2015, Guardant360 in 2018, which are not under insurance coverage, FoundationOne CDx(F1CDx) and OncoGuide NCC Oncopanel system(NCC OP) in 2019, which received approval for insurance coverage for the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neurooncol Adv
Autori principali: Arakawa, Yoshiki, Suga, Junko, Terada, Yukinori, Nakajima, Kohei, Tanji, Masahiro, Mineharu, Yohei, Muto, Manabu, Miyamoto, Susumu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Supplement Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699132/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.099
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi